查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1365773

子宫切除装置市场：按疾病类型、手术方法和最终用户分类：2022-2031 年全球机会分析和产业预测

Hysterectomy Device Market By Disease type, By Surgical approach, By End User : Global Opportunity Analysis and Industry Forecast, 2022-2031
出版日期: | 出版商: Allied Market Research | 英文 389 Pages | 商品交期: 2-3个工作天内

价格

2021年子宫切除设备市场价值为3.2809亿美元，预计2022年至2031年年复合成长率为5.6%，2031年达到5.665亿美元。

子宫切除设备市场-IMG1

子宫切除设备市场的促进因素是子宫内膜患病盛行率的上升。子宫内膜癌是最常见的妇科癌症之一，子宫切除术是此疾病的常见治疗方法。此外，各种政府组织和非政府组织正在提高人们对女性健康的认识，这也促进了市场的成长。此外，子宫切除装置近年来经历了许多技术进步，手术效果得到改善，患者不适减少，恢復时间缩短也促进了市场成长。

然而，治疗妇科疾病的替代治疗方法等要素预计将阻碍子宫切除设备市场的成长。同时，微创手术需求的激增和微创手术预计将为市场提供成长机会。

目录

第1章简介

第2章执行摘要

第3章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响要素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 子宫内膜患病盛行率上升
      • 提高女性健康意识
      • 子宫切除装置的技术进步
    • 抑制因素
      • 替代治疗的可用性
    • 机会
      • 微创手术需求增加
  • COVID-19 市场影响分析

第4章子宫切除装置市场：依疾病类型

  • 概述
  • 子宫癌
  • 子宫肌瘤
  • 慢性骨盆腔疼痛
  • 其他的

第5章子宫切除装置市场：透过手术方法

  • 概述
  • 阴道子宫切除术
  • 腹腔镜子宫切除术
  • 机器人辅助腹腔镜子宫切除术
  • 经腹子宫切除术

第6章子宫切除装置市场：依最终使用者分类

  • 概述
  • 医院
  • 门诊手术中心
  • 其他的

第7章子宫切除装置市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第8章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2021年主要企业定位

第9章公司简介

  • Conkin surgical instruments ltd
  • KARL STORZ GmbH & Co. KG
  • CONMED Corporation
  • Richard Wolf GmbH
  • fortimedix surgical bv
  • Johnson & Johnson
  • Laborie, Inc
  • Cooper Companies, Inc.
  • B. Braun Melsungen AG
  • Medtronic plc
Product Code: A13324

According to a new report published by Allied Market Research, titled, "Hysterectomy Device Market," The hysterectomy device market was valued at $328.09 million in 2021, and is estimated to reach $566.5 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.

Hysterectomy Device Market - IMG1

The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women's health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.

However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy device market analysis from 2021 to 2031 to identify the prevailing hysterectomy device market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hysterectomy device market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hysterectomy device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • SWOT Analysis

Key Market Segments

By Surgical approach

  • Laparoscopic hysterectomy
  • Robotic assisted laparoscopic hysterectomy
  • Abdominal hysterectomy
  • Vaginal hysterectomy

By Disease type

  • Uterine Cancer
  • Fibroids
  • Chronic pelvic pain
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • B. Braun Melsungen AG
    • Conkin surgical instruments ltd
    • CONMED Corporation
    • Cooper Companies, Inc.
    • fortimedix surgical b.v.
    • Johnson & Johnson
    • KARL STORZ GmbH & Co. KG
    • Laborie, Inc
    • Medtronic plc
    • Richard Wolf GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate threat of substitutes
    • 3.3.2. Moderate intensity of rivalry
    • 3.3.3. High bargaining power of buyers
    • 3.3.4. High bargaining power of suppliers
    • 3.3.5. Moderate threat of new entrants
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of uterine cancer
      • 3.4.1.2. Increase in awareness of women's health
      • 3.4.1.3. Technological advancements in hysterectomy devices
    • 3.4.2. Restraints
      • 3.4.2.1. Availability of alternative treatments
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in demand for the minimally invasive procedures
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Uterine Cancer
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Fibroids
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Chronic pelvic pain
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Vaginal hysterectomy
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Laparoscopic hysterectomy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Robotic assisted laparoscopic hysterectomy
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Abdominal hysterectomy
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Disease type
    • 7.2.3. Market size and forecast, by Surgical approach
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Disease type
      • 7.2.5.1.3. Market size and forecast, by Surgical approach
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Disease type
      • 7.2.5.2.3. Market size and forecast, by Surgical approach
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Disease type
      • 7.2.5.3.3. Market size and forecast, by Surgical approach
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Disease type
    • 7.3.3. Market size and forecast, by Surgical approach
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Disease type
      • 7.3.5.1.3. Market size and forecast, by Surgical approach
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Disease type
      • 7.3.5.2.3. Market size and forecast, by Surgical approach
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Disease type
      • 7.3.5.3.3. Market size and forecast, by Surgical approach
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Disease type
      • 7.3.5.4.3. Market size and forecast, by Surgical approach
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Disease type
      • 7.3.5.5.3. Market size and forecast, by Surgical approach
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Disease type
      • 7.3.5.6.3. Market size and forecast, by Surgical approach
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Disease type
    • 7.4.3. Market size and forecast, by Surgical approach
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Disease type
      • 7.4.5.1.3. Market size and forecast, by Surgical approach
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Disease type
      • 7.4.5.2.3. Market size and forecast, by Surgical approach
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Disease type
      • 7.4.5.3.3. Market size and forecast, by Surgical approach
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Disease type
      • 7.4.5.4.3. Market size and forecast, by Surgical approach
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Disease type
      • 7.4.5.5.3. Market size and forecast, by Surgical approach
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Disease type
      • 7.4.5.6.3. Market size and forecast, by Surgical approach
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Disease type
    • 7.5.3. Market size and forecast, by Surgical approach
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Disease type
      • 7.5.5.1.3. Market size and forecast, by Surgical approach
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Disease type
      • 7.5.5.2.3. Market size and forecast, by Surgical approach
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Disease type
      • 7.5.5.3.3. Market size and forecast, by Surgical approach
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Disease type
      • 7.5.5.4.3. Market size and forecast, by Surgical approach
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Conkin surgical instruments ltd
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. KARL STORZ GmbH & Co. KG
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. CONMED Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Richard Wolf GmbH
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. fortimedix surgical b.v.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Johnson & Johnson
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. Laborie, Inc
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Cooper Companies, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. B. Braun Melsungen AG
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Medtronic plc
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 02. HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. GLOBAL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 07. HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. GLOBAL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 12. HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. HYSTERECTOMY DEVICE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 17. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. U.S. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 21. U.S. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 22. U.S. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 23. CANADA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 24. CANADA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 25. CANADA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. MEXICO HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 27. MEXICO HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 28. MEXICO HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 30. EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 31. EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. EUROPE HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 33. GERMANY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 34. GERMANY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 35. GERMANY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. FRANCE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 37. FRANCE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 38. FRANCE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. UK HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 40. UK HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 41. UK HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. ITALY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 43. ITALY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 44. ITALY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. SPAIN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 46. SPAIN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 47. SPAIN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 49. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 50. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 52. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 53. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 54. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 55. JAPAN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 56. JAPAN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 57. JAPAN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. CHINA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 59. CHINA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 60. CHINA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. INDIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 62. INDIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 63. INDIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 65. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 66. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 68. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 69. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 73. LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 74. LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 75. LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 76. LAMEA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 77. BRAZIL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 78. BRAZIL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 79. BRAZIL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 81. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 82. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 84. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 85. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 87. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
  • TABLE 88. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. CONKIN SURGICAL INSTRUMENTS LTD: KEY EXECUTIVES
  • TABLE 90. CONKIN SURGICAL INSTRUMENTS LTD: COMPANY SNAPSHOT
  • TABLE 91. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT SEGMENTS
  • TABLE 92. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT PORTFOLIO
  • TABLE 93. KARL STORZ GMBH & CO. KG: KEY EXECUTIVES
  • TABLE 94. KARL STORZ GMBH & CO. KG: COMPANY SNAPSHOT
  • TABLE 95. KARL STORZ GMBH & CO. KG: PRODUCT SEGMENTS
  • TABLE 96. KARL STORZ GMBH & CO. KG: PRODUCT PORTFOLIO
  • TABLE 97. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 98. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 99. CONMED CORPORATION: PRODUCT SEGMENTS
  • TABLE 100. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 101. RICHARD WOLF GMBH: KEY EXECUTIVES
  • TABLE 102. RICHARD WOLF GMBH: COMPANY SNAPSHOT
  • TABLE 103. RICHARD WOLF GMBH: PRODUCT SEGMENTS
  • TABLE 104. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
  • TABLE 105. FORTIMEDIX SURGICAL B.V.: KEY EXECUTIVES
  • TABLE 106. FORTIMEDIX SURGICAL B.V.: COMPANY SNAPSHOT
  • TABLE 107. FORTIMEDIX SURGICAL B.V.: PRODUCT SEGMENTS
  • TABLE 108. FORTIMEDIX SURGICAL B.V.: PRODUCT PORTFOLIO
  • TABLE 109. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 110. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 111. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 112. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 113. LABORIE, INC: KEY EXECUTIVES
  • TABLE 114. LABORIE, INC: COMPANY SNAPSHOT
  • TABLE 115. LABORIE, INC: PRODUCT SEGMENTS
  • TABLE 116. LABORIE, INC: PRODUCT PORTFOLIO
  • TABLE 117. COOPER COMPANIES, INC.: KEY EXECUTIVES
  • TABLE 118. COOPER COMPANIES, INC.: COMPANY SNAPSHOT
  • TABLE 119. COOPER COMPANIES, INC.: PRODUCT SEGMENTS
  • TABLE 120. COOPER COMPANIES, INC.: PRODUCT PORTFOLIO
  • TABLE 121. COOPER COMPANIES, INC.: KEY STRATERGIES
  • TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 124. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
  • TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. HYSTERECTOMY DEVICE MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF HYSTERECTOMY DEVICE MARKET, 2021-2031
  • FIGURE 03. HYSTERECTOMY DEVICE MARKET,2021-2031
  • FIGURE 04. TOP INVESTMENT POCKETS IN HYSTERECTOMY DEVICE MARKET (2022-2031)
  • FIGURE 05. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 06. MODERATE INTENSITY OF RIVALRY
  • FIGURE 07. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10. GLOBAL HYSTERECTOMY DEVICE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 16. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 21. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 25. HYSTERECTOMY DEVICE MARKET BY REGION, 2021
  • FIGURE 26. U.S. HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. CANADA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. MEXICO HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. GERMANY HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. FRANCE HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. UK HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. ITALY HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SPAIN HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. JAPAN HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. CHINA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. INDIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. AUSTRALIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. BRAZIL HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: HYSTERECTOMY DEVICE MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2021
  • FIGURE 52. CONMED CORPORATION.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. CONMED CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. CONMED CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. COOPER COMPANIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. COOPER COMPANIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 62. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)